Litigation Partner Featured in JAMA Internal Medicine

August 4, 2014
Alan Schwartz, Co-chair of the Products Liability Practice Group, successfully represented the Yale University School of Medicine in opposing an effort by a third party to unblind an ongoing clinical trial designed to determine the effectiveness of a particular drug in preventing recurrent strokes. In a decision of significance to the academic research community, the court agreed that unblinding the trial subjects could jeopardize the scientific integrity of the study and refused to unblind the study.

This matter was of such sufficient importance to the scientific community that it was the subject of a recent article in a peer reviewed journal. See Litigation Seeking Access to Data From Ongoing Clinical Trials: A Threat to Clinical Research. JAMA Intern Med. Published online July 21, 2014. doi:10.1001/jamainternmed.2014.3248.